BioSig Technologies (NASDAQ: BSGM) is a medical technology company which designs and commercializes an innovative signal processing platform. Bio Sig’s signal processing platform is aimed to uncover the full range of ECG and intra-cardiac signals and to improve signal fidelity.
BioSig Technologies
has recently announced that during EPLive 2020, the fifth international symposium on complex
arrhythmias, its
first product, the PURE EP system, would be featured in
several live cases broadcast.
